Analysis of the expression and function of T cell differentiation antigen-CD7
T细胞分化抗原CD7的表达及功能分析
基本信息
- 批准号:05670312
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1.Molecular cloning of mouse Cd7 gene : Four positive clones from BALB/c mouse spleen genomic library were isolated using mouse CD7 cDNA previously reported (Yoshikawa, 1993). These clones covered 24.4kb containing four exons with intervening introns coding for the mouse CD7 antigen. The first exon correspondens to a 5'untranslated (UT) region and the signal peptide, the second exon to the immunoglobulin like region, the third exon to the part of extracellular domain with the transmembrane portion, and the fourth exon to the cytoplasmic tail and 3'UT.When compared to the human CD7 promoter region, nine streches of identical nucleotide sequences as well as a GC box were found. T cell specific expresson may be also defined by streches of nucleotide sequence in 5' flanking regions of either Tcr-V or Thy1 genes in the mouse. We are now inthe process of producing tarageted Cd7 gene disruption mouse to analyze the function of the antigen.2.Production of anti mouse CD7 antibody : Two synthetic peptides (21 and 19 amino acids in the extracellular domain), and mouse CD7 cDNA-and genomic DNA-transfected cells were used for immunization of rabbits and rats. No antibody reactive to mouse thymocytes was, however, obtained to date.3.Production of transgenic mouse : Using 2 constructs from the gene coding for human CD7 antigen reported previously (Yoshikawa, 1991), 7strains of human CD7 gene transgenic mouse were obtained. In only one strain, very week expression of CD7 antigen was observed, while in the rest of 6 strains, the expression was not observed.
1.小鼠CD 7基因的分子克隆:使用先前报道的小鼠CD 7 cDNA(Yoshikawa,1993)从BALB/c小鼠脾基因组文库中分离出4个阳性克隆。这些克隆覆盖24.4kb,含有编码小鼠CD 7抗原的四个外显子和插入的内含子。第一外显子对应于5 '非翻译(UT)区和信号肽,第二外显子对应于免疫球蛋白样区,第三外显子对应于具有跨膜部分的胞外结构域的部分,并且第四外显子对应于胞质尾区和3' UT。发现了9段相同的核苷酸序列和一个GC盒,T细胞特异性表达也可由Tcr-1或Tcr-2的5 ′侧翼区的核苷酸序列确定。V或Thy 1基因。2.抗小鼠CD 7抗体的制备:用两种人工合成的多肽(胞外区21和19个氨基酸)和小鼠CD 7 cDNA及基因组DNA转染的细胞免疫家兔和大鼠。3.转基因小鼠的制备:利用Yoshikawa,1991报道的编码人CD 7抗原基因的2个构建体,获得了7株人CD 7基因转基因小鼠。仅在1株中观察到CD 7抗原的极弱表达,而在其余6株中未观察到CD 7抗原的表达。
项目成果
期刊论文数量(32)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yoshikawa,K.et al: "Isolation and characterization of mouse CD7 cDNA" Immunogenetics. 37. 114-119 (1994)
Yoshikawa,K.et al:“小鼠 CD7 cDNA 的分离和表征”免疫遗传学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Emi, N., Kitaori, K., Seto.M., Ueda, R., Saito, H.and Takahashi, T.: "Isolation of a novel cDNA clone showing marked similarity to ME491/CD63 superfamily." Immunogenetics. 37. 193-198 (1993)
Emi, N.、Kitaori, K.、Seto.M.、Ueda, R.、Saito, H. 和 Takahashi, T.:“分离出与 ME491/CD63 超家族显着相似的新型 cDNA 克隆。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Emi,N.et al: "Isolation of a novel cDNA clone showing marked similarity to ME491/CD63 superfamily." Immunogenetics. 37. 193-198 (1993)
Emi,N.等人:“分离出一种新型 cDNA 克隆,与 ME491/CD63 超家族显示出显着的相似性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Banno, S., Yoshikawa, K., Nakamura, S., Yamamoto, K., Seito, T., Nitta, M., Takahashi, T., Ueda, R.and Seto, M.: "Monoclonal antibody against PRAD1/Cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus." Jpn.J.Cancer Re
Banno, S.、Yoshikawa, K.、Nakamura, S.、Yamamoto, K.、Seito, T.、Nitta, M.、Takahashi, T.、Ueda, R.和 Seto, M.:“针对 PRAD1 的单克隆抗体
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Morita,A.et al: "TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic Tcells" J.Exp.Med.179. 777-784 (1994)
Morita,A.et al:“TL 抗原作为被 TL 限制性细胞毒性 T 细胞识别的移植抗原”J.Exp.Med.179。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIKAWA Kazuhiro其他文献
YOSHIKAWA Kazuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIKAWA Kazuhiro', 18)}}的其他基金
Search for new target antigens of cancer by the SEREX method using cancer patient's serum containing antibodies
利用癌症患者血清中含有的抗体,通过SEREX方法寻找癌症的新靶抗原
- 批准号:
13671680 - 财政年份:2001
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular cloning of highly expressed genes in renal cell carcinoma using cifferential display system
利用差异显示系统分子克隆肾细胞癌高表达基因
- 批准号:
10671502 - 财政年份:1998
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the expression and function of T cell differentiation antigen-CD7
T细胞分化抗原CD7的表达及功能分析
- 批准号:
08670376 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Co-operative Research on Model Analyses for Regional Investment.
区域投资模型分析合作研究。
- 批准号:
02302070 - 财政年份:1990
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Co-operative Research (A)
Co-operative Research on the svstematization and application of Travel behavior model.
出行行为模型系统化及应用合作研究。
- 批准号:
61302065 - 财政年份:1986
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Co-operative Research (A)
相似国自然基金
外泌体ORM1作为肿瘤免疫微环境中T细胞耗竭(T Cell Exhaustion)生物标志物及其功能研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Glut1+ cancer associated fibroblasts enforce a metabolic barrier to tumor T cell infiltration
Glut1癌症相关成纤维细胞增强了肿瘤T细胞浸润的代谢屏障
- 批准号:
10752508 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
- 批准号:
10699815 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Targeting tumor and T cell DNA methylomes to improve CAR T cell therapies for diffuse midline glioma
靶向肿瘤和 T 细胞 DNA 甲基化组以改善弥漫性中线神经胶质瘤的 CAR T 细胞疗法
- 批准号:
10715739 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Bile acid-dependent T cell regulation in the intestine
肠道内胆汁酸依赖性 T 细胞调节
- 批准号:
10767546 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
TOX-driven CD8 T cell differentiation and dysfunction in tumors
TOX驱动的肿瘤中CD8 T细胞分化和功能障碍
- 批准号:
10586679 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Generation of CD8+ Tissue-Resident Memory T cell response during Yersinia pseudotuberculosis foodborne infection
假结核耶尔森菌食源性感染期间 CD8 组织驻留记忆 T 细胞反应的产生
- 批准号:
10572273 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Dissecting the role of hypoxia in T cell differentiation in cancer
剖析缺氧在癌症 T 细胞分化中的作用
- 批准号:
10578000 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
VLA-4–targeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy
VLA-4™ 靶向 67Cu-LLP2A 预处理增强基于 T 细胞的过继免疫疗法的疗效
- 批准号:
10713034 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Selective targeting of a Rho GTPase mutant for peripheral T cell lymphoma treatment
选择性靶向 Rho GTPase 突变体治疗外周 T 细胞淋巴瘤
- 批准号:
10721439 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:














{{item.name}}会员




